HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoling Su Selected Research

dapagliflozin

1/2022Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoling Su Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 01/2015
6Infections
03/2024 - 01/2021
2COVID-19
03/2024 - 12/2022
2Reperfusion Injury
07/2023 - 06/2023
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2023 - 06/2023
2Hypertension (High Blood Pressure)
11/2022 - 10/2022
2Heart Failure
10/2022 - 01/2022
2Cardiac Arrhythmias (Arrythmia)
10/2022 - 01/2022
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 01/2018
1Breakthrough Infections
12/2023
1Reinfection
12/2023
1Communicable Diseases (Infectious Diseases)
12/2023
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023
1Inflammation (Inflammations)
01/2023
1Left Ventricular Dysfunction
01/2022
1Pulmonary Arterial Hypertension
01/2022
1Chronic Hepatitis B
11/2021
1Virus Diseases (Viral Diseases)
10/2021
1Coronary Disease (Coronary Heart Disease)
03/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Cardiomegaly (Heart Hypertrophy)
09/2020
1Hypertrophy
09/2020
1Fistula
12/2019
1Pathologic Constriction (Stenosis)
12/2019
1Endometrial Neoplasms (Endometrial Cancer)
01/2019
1Weight Loss (Weight Reduction)
09/2017
1Carcinoma (Carcinomatosis)
09/2017
1Spontaneous Abortion (Miscarriage)
06/2017
1Osteoarthritis
01/2017
1Disease Progression
01/2017
1Fibrosis (Cirrhosis)
01/2016

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
3Neutralizing AntibodiesIBA
03/2024 - 12/2022
3Lysine (L-Lysine)FDA Link
07/2023 - 07/2022
3MicroRNAs (MicroRNA)IBA
06/2023 - 01/2018
2VaccinesIBA
03/2024 - 01/2021
2Messenger RNA (mRNA)IBA
03/2024 - 06/2017
2Inactivated VaccinesIBA
03/2024 - 12/2023
2CalciumIBA
10/2022 - 01/2022
2Antiviral Agents (Antivirals)IBA
07/2022 - 01/2016
2Competitive Endogenous RNAIBA
01/2019 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2017
1mRNA VaccinesIBA
03/2024
1AntigensIBA
12/2023
1Annexin A2 (Annexin II)IBA
12/2023
1LigandsIBA
12/2023
1Lipoproteins (Lipoprotein)IBA
01/2023
1CrizotinibIBA
01/2023
1alectinibIBA
01/2023
1C-Type Lectins (C-Type Lectin)IBA
01/2023
1Immunoglobulin G (IgG)IBA
12/2022
1EpitopesIBA
12/2022
1Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2022
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1dapagliflozinIBA
01/2022
1SodiumIBA
01/2022
1Hepatitis B e AntigensIBA
11/2021
1feralIBA
10/2021
1Peptides (Polypeptides)IBA
10/2021
1Histocompatibility Antigens Class IIBA
10/2021
1CholesterolIBA
03/2021
1ExotoxinsIBA
01/2021
1Contrast MediaIBA
01/2021
1myosin light chain 2IBA
09/2020
1calpain inhibitorsIBA
09/2020
1Myosin-Light-Chain KinaseIBA
09/2020
1calpeptinIBA
09/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2020
1CalpainIBA
09/2020
1Isoproterenol (Isoprenaline)FDA LinkGeneric
09/2020
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2018
1PlatinumIBA
09/2017
1cuprous oxideIBA
09/2017
1Cisplatin (Platino)FDA LinkGeneric
09/2017
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2017
1IsotopesIBA
01/2017
1Fenofibrate (CiL)FDA LinkGeneric
01/2017

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2023 - 09/2017
1Aftercare (After-Treatment)
12/2019